Skip to content

Aurobindo Pharma Limited Price, Chart & Factor Exposure

Free Data & Analytics Access

Next earnings: Tue, Feb 9, 2027, before the market opens · estimates and history

Aurobindo Pharma Limited · E.AUROPHARMA.NSE · India
Use symbol E.AUROPHARMA.NSE in our API & Excel add-in to retrieve this data ↓
1,683.80
(+0.00%)
? Live Prices updated every 5-seconds. Momentum Factor ranges from -100 to +100 and is the mean of four timeframe signals (1 Day, 1 Week, 1 Month, 3 Months), where each timeframe is +1 if return is above 0 and -1 otherwise. Trend Factor ranges from -100 to +100 and is the mean of eight signals across 1-month, 3-months, 6-months, and 1-year, using price vs moving average and moving average slope (+1 or -1). A rollover occurs when trend flips sign. Bubble Risk is the z-score of current price vs 1-year price: (Current Price - 250 trading days SMA) / (250 days price standard deviation). Values above +2.5 indicate overbought; below -2.5 oversold. Realized Volatility (20-days) is the standard deviation of daily returns over the past 20 trading days multiplied by sqrt(252).
Momentum 100%
Trend 100%
Bubble Risk LOW
Realised Volatility (20D) 26.52%

Aurobindo Pharma Limited Forecast

Aurobindo Pharma Limited short-term momentum is strongly positive (up over 4 of 4 look-backs: 5, 10, 20 and 30 trading days), a short-term BUY signal. The long-term trend is strongly positive (8 of 8 checks up: price above, and slope of, its 50-, 100-, 150- and 200-day averages), a long-term BUY signal. Based on 20-day realised volatility of 26.5% a year, a typical one-standard-deviation range is 1,621–1,747 over a week, 1,555–1,813 over a month and 1,237–2,130 over a year. (Signals as of 5 Nov 2026.)

Aurobindo Pharma Limited Price Chart

MacroFinance.ai

Aurobindo Pharma Limited Factors

Test factors in Return analysis →
Market/MacroIndicatorNowChangeRange
Quantitative
Aurobindo Pharma Limited
Momentum (composite)
—
ⓘLatest reading of Momentum (composite).
Aurobindo Pharma Limited
Relative Volume (21d)
—
ⓘLatest reading of Relative Volume (21d).
Aurobindo Pharma Limited
Signal
0
ⓘLatest reading of Signal.
Fundamental
Valuation
Aurobindo Pharma Limited
P/E
24.28x
Mid-range vs own history
QoQ −3.8%
YoY +18.7%
now 24.281118.86 low27 high
ⓘP/E As of 22 Nov 2026.See Aurobindo Pharma Limited returns when P/E looked like now →Opens Return analysis with the filter P/E within ±5% of today
Aurobindo Pharma Limited
P/S
2.63x
Stretched vs own history
QoQ −2.2%
YoY +22.0%
now 2.62791.98 low2.87 high
ⓘP/S As of 22 Nov 2026.See Aurobindo Pharma Limited returns when P/S looked like now →Opens Return analysis with the filter P/S within ±5% of today
Aurobindo Pharma Limited
P/B
2.46x
Stretched vs own history
QoQ −0.6%
YoY +23.0%
now 2.4591.88 low2.66 high
ⓘP/B As of 22 Nov 2026.See Aurobindo Pharma Limited returns when P/B looked like now →Opens Return analysis with the filter P/B within ±5% of today
Aurobindo Pharma Limited
EV/EBITDA
11.91x
Mid-range vs own history
QoQ −2.8%
YoY +18.4%
now 11.90899.97 low12.91 high
ⓘEV/EBITDA As of 22 Nov 2026.See Aurobindo Pharma Limited returns when EV/EBITDA looked like now →Opens Return analysis with the filter EV/EBITDA within ±5% of today
Aurobindo Pharma Limited
EV/Sales
2.59x
Stretched vs own history
QoQ −0.7%
YoY +22.2%
now 2.59132.1 low2.81 high
ⓘEV/Sales As of 22 Nov 2026.See Aurobindo Pharma Limited returns when EV/Sales looked like now →Opens Return analysis with the filter EV/Sales within ±5% of today
Aurobindo Pharma Limited
Earnings Yield
4.1%
Mid-range vs own history
QoQ +4.0%
YoY −15.7%
now 4.11843.7 low5.3 high
ⓘEarnings Yield As of 22 Nov 2026.See Aurobindo Pharma Limited returns when Earnings Yield looked like now →Opens Return analysis with the filter Earnings Yield within ±5% of today
Aurobindo Pharma Limited
Market Cap
$968.9B
Highest in 5 years
QoQ +3.4%
YoY +38.3%
now 968858.52657,758 low1,049,069 high
ⓘMarket Cap As of 22 Nov 2026.See Aurobindo Pharma Limited returns when Market Cap looked like now →Opens Return analysis with the filter Market Cap within ±5% of today
Balance-Sheet Health
Aurobindo Pharma Limited
Net Debt
-$13.5B
Mid-range vs own history
QoQ −47.0%
YoY +22.8%
now -13481.5-25,447 low-10,979 high
ⓘNet Debt As of 22 Nov 2026.See Aurobindo Pharma Limited returns when Net Debt looked like now →Opens Return analysis with the filter Net Debt within ±5% of today
Aurobindo Pharma Limited
Net Debt / EBITDA
-0.17x
Mid-range vs own history
QoQ −52.7%
YoY +4.9%
now -0.168-0.36 low-0.16 high
ⓘNet Debt / EBITDA As of 22 Nov 2026.See Aurobindo Pharma Limited returns when Net Debt / EBITDA looked like now →Opens Return analysis with the filter Net Debt / EBITDA within ±5% of today
Aurobindo Pharma Limited
Current Ratio
1.73x
Weak vs own history
QoQ −4.8%
YoY −6.6%
now 1.72671.73 low1.85 high
ⓘCurrent Ratio As of 22 Nov 2026.See Aurobindo Pharma Limited returns when Current Ratio looked like now →Opens Return analysis with the filter Current Ratio within ±5% of today
Aurobindo Pharma Limited
Quick Ratio
1.06x
Weak vs own history
QoQ −7.5%
YoY −5.9%
now 1.05931.06 low1.15 high
ⓘQuick Ratio As of 22 Nov 2026.See Aurobindo Pharma Limited returns when Quick Ratio looked like now →Opens Return analysis with the filter Quick Ratio within ±5% of today
Aurobindo Pharma Limited
Interest Coverage
15.35x
Mid-range vs own history
QoQ +2.6%
YoY +27.0%
now 15.350412.09 low15.35 high
ⓘInterest Coverage As of 22 Nov 2026.See Aurobindo Pharma Limited returns when Interest Coverage looked like now →Opens Return analysis with the filter Interest Coverage within ±5% of today
Aurobindo Pharma Limited
Debt / Equity
0.22x
Mid-range vs own history
QoQ +2.8%
YoY −1.5%
now 0.2190.21 low0.22 high
ⓘDebt / Equity As of 22 Nov 2026.See Aurobindo Pharma Limited returns when Debt / Equity looked like now →Opens Return analysis with the filter Debt / Equity within ±5% of today
Aurobindo Pharma Limited
Piotroski F-Score
4
Mid-range vs own history
QoQ +33.3%
YoY 0.0%
now 43 low4 high
ⓘPiotroski F-Score As of 22 Nov 2026.See Aurobindo Pharma Limited returns when Piotroski F-Score looked like now →Opens Return analysis with the filter Piotroski F-Score within ±5% of today
  15 members-only factors: Revenue Growth, Revenue CAGR 3Y, Earnings Growth, EBITDA Growth and moreSign up
Accounting Red Flags
  15 members-only factors: Beneish M-Score, Days Sales in Receivables Index, Gross Margin Index, Asset Quality Index and moreSign up
Global Risk
  22 members-only factors: MacroFinance Risk Index, VIX, VSTOXX, VIX Term Structure and moreSign up
Teal = supportive for Aurobindo Pharma Limited, red = a headwind, grey = neutral. Hover or tap ⓘ for how each factor works and to see returns in similar conditions.

Aurobindo Pharma Limited fundamentals: income statement, balance sheet & cash flow

Aurobindo Pharma Limited reported revenue of 336.53bn INR and net income of 35.05bn INR in FY2026, the year ended 31 March 2026 — revenue up 6.1% and net income up 0.5% on the prior year. Free cash flow was 28.27bn INR. These figures are as reported in the filings, not restated: 23 fiscal years and 60 quarters of history, back to March 2004.

Revenue (FY2026)
336.53bn INR
+6.1%
Net income
35.05bn INR
+0.5%
Gross margin
39.21%
Free cash flow
28.27bn INR
+44.5%
Net debt
-17.97bn INR
Aurobindo Pharma Limited income statement, annual, as reported · INR billions unless stated
INR billionsFY2026FY2025FY2024FY2023FY2022
Period end31 Mar 202631 Mar 202531 Mar 202431 Mar 202331 Mar 2022
Revenue336.53317.24290.02248.55234.55
Cost of revenue204.57134.84129.86116.42104.50
Gross profit131.96182.40160.16132.14130.06
Research & development1.5516.9215.2214.5316.25
Selling, general & admin.79.63—40.4336.5635.75
Operating income50.78120.01104.5081.0578.06
EBITDA72.7465.7858.8337.5644.33
Interest expense3.844.572.901.400.49
Pre-tax income51.1250.6643.8026.1333.73
Income tax16.0915.8312.116.857.26
Net income35.0534.8631.7319.2826.48

Download Aurobindo Pharma Limited fundamentals

Get the fundamentals as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_fundamentals&symbol=E.AUROPHARMA.NSE&statement=all&freq=a&format=csv&years=10
DownloadLast 10 fiscal years, no login.
The free download stops at 10 fiscal years. A free account unlocks all 23 fiscal years and 60 quarters, the filing vintages behind each number and API access.
Create free account

Figures in INR, statements as filed. A cell is left blank where the filing does not report it or where the reported figure fails the statement’s own arithmetic.

Research on Aurobindo Pharma Limited

Explore MacroFinance macro & markets research and analysis.

Browse all financial research →

Aurobindo Pharma Limited Trading Strategies

28 backtested tactical asset allocation strategies hold EEM (emerging markets), the closest tradable exposure to Aurobindo Pharma Limited; 2 of them are invested now. Strategies currently invested are listed first.

Hypothetical backtests over each ETF's own history; past performance does not guarantee future results. Upgrade to see every strategy's allocation and performance.

See all 28 strategies holding EEM →

Statistical Distribution of Returns

Plus

How Aurobindo Pharma Limited’s returns are distributed — and how they change in a given market regime.

Regime filters

Market/Macro Indicator Criteria Value And (for Between) Action

No regime filter yet — the chart below shows every period. Add a factor condition, or pick a popular regime.

MacroFinance.ai
Full return statistics
Statistic All periods Matching
  Sharpe, maximum drawdown and the full percentile table are part of Plus. Unlock with Plus
Know how Aurobindo Pharma Limited behaves before the regime turns Plus unlocks the full return history, unlimited factor conditions, regime-versus-baseline statistics and export — on every market, stock, ETF and index.

About Aurobindo Pharma Limited (India)

Aurobindo Pharma Limited is a listed security in India. This page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data (the last 10 years as CSV or JSON, no login).

Last updated: November 22, 2026

Frequently asked questions

What is Aurobindo Pharma Limited?
Aurobindo Pharma Limited is a listed security in India. On MacroFinance its page shows the latest price and daily change, a price chart, momentum, trend, bubble-risk and volatility signals, its factor exposures, the statistical distribution of its returns, the trading strategies that hold it and free historical data.
What is the latest Aurobindo Pharma Limited price?
The latest close is 1,684 (5 Nov 2026), +0.00% on the day. The price at the top of the page refreshes during the trading day.
Is Aurobindo Pharma Limited in an uptrend?
As of 5 Nov 2026, short-term momentum is strongly positive (4 of 4 look-backs up: 5, 10, 20 and 30 trading days) and the long-term trend is strongly positive (8 of 8 checks up on its 50- to 200-day moving averages). Bullish when both are positive, bearish when both are negative.
How volatile is Aurobindo Pharma Limited?
20-day realised volatility is 26.5% a year (5 Nov 2026), which implies a typical one-standard-deviation move of about 7.7% over a month and 3.7% over a week.
What factors affect Aurobindo Pharma Limited?
The Factors section lists the signals, relative-value, risk-model and macro factors linked to Aurobindo Pharma Limited, grouped as Quantitative Factors, Fundamental Factors, Accounting Red Flags, Global Risk Factors, each with its latest reading. Some factors are open to everyone; the rest need a MacroFinance plan.
Which trading strategies trade Aurobindo Pharma Limited?
28 backtested tactical asset allocation strategies trade Aurobindo Pharma Limited through EEM; 2 of them hold it now. The Trading Strategies section lists them with their current weight, CAGR, Sharpe ratio and maximum drawdown.
How are Aurobindo Pharma Limited returns analysed?
The Statistical Distribution of Returns section shows the distribution of Aurobindo Pharma Limited daily, weekly, monthly, 2-month and 3-month returns with count, annualised average return, volatility, Sharpe ratio and maximum drawdown, and lets you filter the history by factor conditions, e.g. only periods when momentum was positive. A free account tests up to 2 factor conditions over the last 1 year of history; a Plus plan unlocks the full history, unlimited conditions, the regime statistics and the export.
Where can I download free Aurobindo Pharma Limited historical data?
In the Free historical data section of this page: the last 10 years of Aurobindo Pharma Limited daily closes as CSV or JSON, no login needed. A free account unlocks the full history, Excel and API access.

Free Aurobindo Pharma Limited historical data (last 10 years)

Browse or instantly download the last 10 years of Aurobindo Pharma Limited daily price history. A free account unlocks the full history, an Excel export with factors, and API access.

Get the data as
https://macrofinance.ai/wp-admin/admin-ajax.php?action=mf_history&symbol=E.AUROPHARMA.NSE&format=csv&years=10
DownloadLast 10 years, no login.
DateClose
2026-11-201799
2026-11-191805.7
2026-11-181796.3
2026-11-171794.1
2026-11-161794
2026-11-131823.2
2026-11-121807.2
2026-11-111827.5
2026-11-091848.3
2026-11-081797.19
Loading last 10 years…
The table and downloads stop at 10 years. A free account unlocks the full history, the Excel add-in and API access.
Create free account

About this stock

Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally. The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectables for generic pharmaceuticals, branded specialty pharmaceuticals, and active pharmaceutical ingredients for CNS, anti-retroviral, cardiovascular, antibiotics, gastroenterology, anti-diabetics, and anti-allergic therapeutic areas. It also provides ointments, creams, gels, powders, transdermal, and lotions; antiretroviral drugs for PLHIV & CLHIV; and injectable products, including Penems, Penicillin, Cephalosporin, ophthalmic, inhalation, oncology, and hormone products. The company was incorporated in 1986 and is headquartered in Hyderabad, India.